Accurate classification of BRCA1 variants with saturation genome editing
GM Findlay, RM Daza, B Martin, MD Zhang, AP Leith… - Nature, 2018 - nature.com
Nature, 2018•nature.com
Variants of uncertain significance fundamentally limit the clinical utility of genetic information.
The challenge they pose is epitomized by BRCA1, a tumour suppressor gene in which
germline loss-of-function variants predispose women to breast and ovarian cancer. Although
BRCA1 has been sequenced in millions of women, the risk associated with most newly
observed variants cannot be definitively assigned. Here we use saturation genome editing
to assay 96.5% of all possible single-nucleotide variants (SNVs) in 13 exons that encode …
The challenge they pose is epitomized by BRCA1, a tumour suppressor gene in which
germline loss-of-function variants predispose women to breast and ovarian cancer. Although
BRCA1 has been sequenced in millions of women, the risk associated with most newly
observed variants cannot be definitively assigned. Here we use saturation genome editing
to assay 96.5% of all possible single-nucleotide variants (SNVs) in 13 exons that encode …
Abstract
Variants of uncertain significance fundamentally limit the clinical utility of genetic information. The challenge they pose is epitomized by BRCA1, a tumour suppressor gene in which germline loss-of-function variants predispose women to breast and ovarian cancer. Although BRCA1 has been sequenced in millions of women, the risk associated with most newly observed variants cannot be definitively assigned. Here we use saturation genome editing to assay 96.5% of all possible single-nucleotide variants (SNVs) in 13 exons that encode functionally critical domains of BRCA1. Functional effects for nearly 4,000 SNVs are bimodally distributed and almost perfectly concordant with established assessments of pathogenicity. Over 400 non-functional missense SNVs are identified, as well as around 300 SNVs that disrupt expression. We predict that these results will be immediately useful for the clinical interpretation of BRCA1 variants, and that this approach can be extended to overcome the challenge of variants of uncertain significance in additional clinically actionable genes.
nature.com
以上显示的是最相近的搜索结果。 查看全部搜索结果